platinum has been researched along with morphinans in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Li, L; Ma, YJ; Ren, XN; Zhou, M; Zhou, XY | 1 |
| Fujii, H; Hasebe, K; Mochizuki, H; Nagase, H; Nakajima, M; Nemoto, T; Ogawa, R; Ohata, K | 1 |
| Bernardes, GJL; Caramori, GF; Conde, J; Cordeiro, C; de Almeida, CR; Domingos, JB; Ferreira, MG; Fior, R; Negrão, M; Oliveira, BL; Schneider, FSS; Stenton, BJ; Unnikrishnan, VB | 1 |
3 other study(ies) available for platinum and morphinans
| Article | Year |
|---|---|
Determination of sinomenine in Sinomenium acutum by capillary electrophoresis with electrochemiluminescence detection.
Topics: Calibration; Electrochemistry; Electrodes; Electrolytes; Electrophoresis, Capillary; Ferrocyanides; Hydrogen-Ion Concentration; Luminescence; Medicine, Chinese Traditional; Morphinans; Phosphates; Plant Extracts; Platinum; Rubidium; Solvents | 2007 |
Aerobic oxidation of indolomorphinan without the 4,5-epoxy bridge and subsequent rearrangement of the oxidation product to spiroindolinonyl-C-normorphinan derivative.
Topics: Catalysis; Competitive Bidding; Morphinans; Oxidation-Reduction; Platinum; Receptors, Opioid, delta; Receptors, Opioid, mu | 2009 |
Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and
Topics: Amides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Liberation; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Morphinans; Neoplasms, Experimental; Platinum; Zebrafish | 2020 |